Australia-China Biotech Invest & Partnering
Date: Thursday 28 – Friday 29 March 2019
Venue: Marriott City Centre, Shanghai
555 Xizang Middle Rd, Huangpu Qu
Shanghai Shi, China, 200003
Phone: +86 21 2312 9888
Visit Marriott City Centre website
AusBiotech will again host the Asian investment series in March 2019, leading a delegation of Australian life science companies to two major investment hubs in Asia and connecting Australian companies and international investors.
With Asia rapidly emerging as a driver of growth in biotechnology research and investment, these events provide a critical opportunity for Australian life science companies to present their business case and leverage the booming Asian opportunity, a point echoed by Neuroscience Trials Australia CEO, Dr Tina Soulis, who was part of the 2018 delegation. “As first-time attendees to an Asian mission (and part of the Shanghai delegation), the whole event exceeded our expectations,” Dr Soulis said. “The number of quality attendees were high, the engagement and interest in the Australian clinical trial landscape genuine and the event well organised. It was well worth us attending as the interest in engaging Australia definitely there.”
Both the Hong Kong and Shanghai events are expected to attract more than 150 investors and will feature up to 20 Australian life science companies across each event. Presentation spots are limited, so please forward your expressions of interest by 15 December to secure your opening on the program. Companies can present in Hong Kong and Shanghai with discounts available for presenting at both events.
For further information on presentation and sponsorship opportunities please contact email@example.com or phone +61 3 9828 1400. Company presentation packages and investor registration are also available at www.ausbiotechinvestment.com.au